UK government launches drug-free anti-depression therapy

23 April 2006

The Health Secretary for England and Wales has launched a program to attempt "drug-free" therapy for depression, a condition that is estimated to cost the National Health Service L400.0 million ($709.2 million) per year.

Two pilot schemes, believed to be based in South Doncaster and the Borough of Newham in London, will be designated so that patients in those areas are offered a range of counselling treatments. The selected areas have a relatively high proportion of residents who claim incapacity benefit, out of which a third are expected to be suffering from depression. The total UK budget on incapacity benefit is L10.0 billion.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight